Bharat Dixit

Bharat Dixit serves as the Chief Technology Officer at Adiso Therapeutics and ClearB Therapeutics, both of which are part of the Morningside Portfolio, since January 2022 and April 2019, respectively. Prior to these roles, Bharat held key positions in various companies, including Vice President of Biopharmaceutical Development & Manufacturing at Artugen Therapeutics and Vice President of Bioprocess & Analytical Development at Finch Therapeutics Group. Bharat's extensive experience in the biopharmaceutical sector includes significant roles at Genocea Biosciences and Sanofi Pasteur. Academic credentials include a PhD in Biochemistry from the Institute of Microbial Technology and an MSc in Life Sciences from the Indian Institute of Technology, Roorkee.